These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7546047)

  • 41. Synthesis and anti-Trypanosoma cruzi activity of β-lapachone analogues.
    Ferreira SB; Salomão K; de Carvalho da Silva F; Pinto AV; Kaiser CR; Pinto AC; Ferreira VF; de Castro SL
    Eur J Med Chem; 2011 Jul; 46(7):3071-7. PubMed ID: 21450374
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro and in vivo effects of itraconazole against Trypanosoma cruzi.
    McCabe RE; Remington JS; Araujo FG
    Am J Trop Med Hyg; 1986 Mar; 35(2):280-4. PubMed ID: 3006529
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Natural and synthetic naphthoquinones active against Trypanosoma cruzi: an initial step towards new drugs for Chagas disease.
    Salas CO; Faúndez M; Morello A; Maya JD; Tapia RA
    Curr Med Chem; 2011; 18(1):144-61. PubMed ID: 21110810
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Primaquine analogues that are potent anti-Trypanosoma cruzi agents in a mouse model.
    Kinnamon KE; Poon BT; Hanson WL; Waits VB
    Ann Trop Med Parasitol; 1996 Oct; 90(5):467-74. PubMed ID: 8915122
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Trypanocidal effects of promethazine.
    Fernández AR; Fretes R; Rubiales S; Lacuara JL; Paglini-Oliva P
    Medicina (B Aires); 1997; 57(1):59-63. PubMed ID: 9435371
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The chemotherapy of Chagas disease].
    Stoppani AO
    Medicina (B Aires); 1999; 59 Suppl 2():147-65. PubMed ID: 10668258
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New alkenyl derivative from Piper malacophyllum and analogues: Antiparasitic activity against Trypanosoma cruzi and Leishmania infantum.
    Varela MT; Lima ML; Galuppo MK; Tempone AG; de Oliveira A; Lago JHG; Fernandes JPS
    Chem Biol Drug Des; 2017 Nov; 90(5):1007-1011. PubMed ID: 28371557
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Semisynthesis of new aphidicolin derivatives with high activity against Trypanosoma cruzi.
    Santos GB; Krogh R; Magalhaes LG; Andricopulo AD; Pupo MT; Emery FS
    Bioorg Med Chem Lett; 2016 Feb; 26(4):1205-8. PubMed ID: 26810263
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Two analogues of fenarimol show curative activity in an experimental model of Chagas disease.
    Keenan M; Chaplin JH; Alexander PW; Abbott MJ; Best WM; Khong A; Botero A; Perez C; Cornwall S; Thompson RA; White KL; Shackleford DM; Koltun M; Chiu FC; Morizzi J; Ryan E; Campbell M; von Geldern TW; Scandale I; Chatelain E; Charman SA
    J Med Chem; 2013 Dec; 56(24):10158-70. PubMed ID: 24304150
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Trypanothione Reductase: A Target for the Development of Anti- Trypanosoma cruzi Drugs.
    Vázquez K; Paulino M; Salas CO; Zarate-Ramos JJ; Vera B; Rivera G
    Mini Rev Med Chem; 2017; 17(11):939-946. PubMed ID: 28302040
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combined use of ascorbic acid and cyanocobalamin in clearance of Trypanosoma cruzi.
    Ghobadifar MA; Kalani N; Gitiforouz M
    Expert Rev Clin Pharmacol; 2014 Jul; 7(4):401-2. PubMed ID: 24857404
    [No Abstract]   [Full Text] [Related]  

  • 52. Toxic effects of natural piperine and its derivatives on epimastigotes and amastigotes of Trypanosoma cruzi.
    Ribeiro TS; Freire-de-Lima L; Previato JO; Mendonça-Previato L; Heise N; de Lima ME
    Bioorg Med Chem Lett; 2004 Jul; 14(13):3555-8. PubMed ID: 15177472
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The in vivo trypanocidal effect of the diterpene 5-epi-icetexone obtained from Salvia gilliesii.
    Lozano E; Strauss M; Spina R; Cifuente D; Tonn C; Rivarola HW; Sosa MA
    Parasitol Int; 2016 Feb; 65(1):23-26. PubMed ID: 26341064
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Revisiting Pyrazolo[3,4-
    Bouton J; Ferreira de Almeida Fiuza L; Cardoso Santos C; Mazzarella MA; Soeiro MNC; Maes L; Karalic I; Caljon G; Van Calenbergh S
    J Med Chem; 2021 Apr; 64(7):4206-4238. PubMed ID: 33784107
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antitrypanosomal Activity of Sterol 14α-Demethylase (CYP51) Inhibitors VNI and VFV in the Swiss Mouse Models of Chagas Disease Induced by the Trypanosoma cruzi Y Strain.
    Guedes-da-Silva FH; Batista DG; Da Silva CF; De Araújo JS; Pavão BP; Simões-Silva MR; Batista MM; Demarque KC; Moreira OC; Britto C; Lepesheva GI; Soeiro MN
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167559
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Trypanosoma cruzi: in vitro and in vivo antiproliferative effects of epigallocatechin gallate (EGCg).
    Güida MC; Esteva MI; Camino A; Flawiá MM; Torres HN; Paveto C
    Exp Parasitol; 2007 Oct; 117(2):188-94. PubMed ID: 17673202
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risedronate in the treatment of Murine Chagas' disease.
    Bouzahzah B; Jelicks LA; Morris SA; Weiss LM; Tanowitz HB
    Parasitol Res; 2005 Jun; 96(3):184-7. PubMed ID: 15844009
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In Vitro Image-Based Assay for Trypanosoma cruzi Intracellular Forms.
    Eufrásio AG; Cordeiro AT
    Methods Mol Biol; 2020; 2116():773-780. PubMed ID: 32221954
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antitrypanosomal activity of Senna villosa in infected BALB/c mice with Trypanosoma cruzi during the sub acute phase of infection.
    Jimenez-Coello M; Guzman-Marin E; Perez-Gutierrez S; Polanco-Hernandez GM; Acosta-Viana KY
    Afr J Tradit Complement Altern Med; 2011; 8(5 Suppl):164-9. PubMed ID: 22754070
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Treatment of Chagas' disease].
    Apt W
    Rev Med Chil; 1985 Feb; 113(2):162-6. PubMed ID: 3936147
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.